Breaking News

PCI Completes Penn Acquisition

August 4, 2014

Expands service offerings across North America and Europe

Packaging Coordinators, Inc. (PCI) has finalized its acquisition of Penn Pharmaceutical Services Ltd., a provider of drug development and manufacturing services headquartered in Wales, UK. Penn offers clinical and commercial dosage form manufacturing and packaging, labeling, and global storage, distribution and return drug services.

With the acquisition PCI and Penn Pharma’s approximately 2,800 associates will combine across 15 facilities in North America and Europe. 
 
PCI is principally owned by Frazier Healthcare, with partner investors QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners. Teneo Capital acted as the exclusive financial adviser to PCI and Frazier Healthcare, professional services firm Alvarez & Marsal provided due diligence services, and Goodwin Procter LLP acted as legal counsel for the transaction.
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer